Back to search

Article

Seizures Triggered by Systemic Administration of 4-Aminopyridine Lead to Acute Brain Glucose Hypometabolism in Rats, as Assessed by PET Molecular Imaging

2024-10-25

Abstract excerpt

4-aminopyridine (4-AP) is a non-selective blocker of voltage-dependent K+ channels used to im-prove walking in multiple sclerosis patients, and it may be useful in the treatment of cerebellar diseases. In animal models, 4-AP is used as a convulsant agent. Intrahippocampal 4-AP induces acute local glucose hypermetabolism and significant brain damage, while i.p. administration causes less neuronal damage. This study...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
deab17b5-a3af-5122-b60b-adbf7a1ec6f5
DOI
10.20944/preprints202410.2027.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Seizures Triggered by Systemic Administration of 4-Aminopyridine Lead to Acute Brain Glucose Hypometabolism in Rats, as Assessed by PET Molecular ImagingDOI 10.20944/preprints202410.2027.v1
Select a neighboring publication to make it the new centre.